Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States.

Stoecker, Charles; Kim, Lindsay; Gierke, Ryan; Pilishvili, Tamara

Stoecker, Charles; Kim, Lindsay; Gierke, Ryan; Pilishvili, Tamara.

Affiliation

Stoecker C; Department of Global Health Management and Policy, Tulane University School of Public Health and Tropical Medicine, 1440 Canal St #8346, New Orleans, LA, 70112, USA. cfstoecker@tulane.edu.
Kim L; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Gierke R; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Pilishvili T; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

J Gen Intern Med ; 31(8): 901-8, 2016 08.

Article de En | MEDLINE | ID: mdl-26976292

Sujet(s)
Mots clés

cost-effectiveness; pneumococcal disease; vaccinations

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à pneumocoques / Analyse coût-bénéfice / Vaccins conjugués / Vaccins antipneumococciques Type d'étude: Clinical_trials / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limites: Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: America do norte Langue: En Journal: J Gen Intern Med Sujet du journal: MEDICINA INTERNA Année: 2016 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google